Yakira Capital Management’s SAB Biotherapeutics, Inc. Warrant SABSW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-78,733
| Closed | -$2.35K | – | 221 |
|
|
2025
Q1 | $2.35K | Sell |
78,733
-14,497
| -16% | -$433 | ﹤0.01% | 187 |
|
|
2024
Q4 | $7.02K | Sell |
93,230
-15,255
| -14% | -$1.15K | ﹤0.01% | 175 |
|
|
2024
Q3 | $3.91K | Hold |
108,485
| – | – | ﹤0.01% | 208 |
|
|
2024
Q2 | $5.14K | Hold |
108,485
| – | – | ﹤0.01% | 209 |
|
|
2024
Q1 | $3.93K | Hold |
108,485
| – | – | ﹤0.01% | 252 |
|
|
2023
Q4 | $3.28K | Hold |
108,485
| – | – | ﹤0.01% | 262 |
|
|
2023
Q3 | $8.14K | Hold |
108,485
| – | – | ﹤0.01% | 261 |
|
|
2023
Q2 | $11.3K | Hold |
108,485
| – | – | ﹤0.01% | 244 |
|
|
2023
Q1 | $6.12K | Hold |
108,485
| – | – | ﹤0.01% | 301 |
|
|
2022
Q4 | $5.1K | Hold |
108,485
| – | – | ﹤0.01% | 305 |
|
|
2022
Q3 | $7K | Hold |
108,485
| – | – | ﹤0.01% | 377 |
|
|
2022
Q2 | $17K | Hold |
108,485
| – | – | ﹤0.01% | 334 |
|
|
2022
Q1 | $52K | Sell |
108,485
-7,300
| -6% | -$3.5K | 0.01% | 356 |
|
|
2021
Q4 | $207K | Sell |
115,785
-9,214
| -7% | -$16.5K | 0.03% | 294 |
|
|
2021
Q3 | $115K | Hold |
124,999
| – | – | 0.02% | 291 |
|
|
2021
Q2 | $115K | Buy |
+124,999
| New | +$115K | 0.02% | 301 |
|